| 11938156 |
Lactic acid bacteria and its applications |
Ying-Chieh Tsai, Chien-Chen Wu, Jyh-Shing Hsu |
2024-03-26 |
| 11335437 |
Set membership testers for aligning nucleic acid samples |
Erich D. Blume, John P. Burke |
2022-05-17 |
| 10988433 |
Cyclohexyl GPR40 agonists for the treatment of type II diabetes |
James C. Lanter, Sanath K. Meegalla, Mark R. Player |
2021-04-27 |
| 10662170 |
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes |
Gee-Hong Kuo, Mark R. Player, Shyh-Ming Yang, Yue-Mei Zhang |
2020-05-26 |
| 10131648 |
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes |
Gee-Hong Kuo, Mark R. Player, Shyh-Ming Yang, Yue-Mei Zhang |
2018-11-20 |
| 10106553 |
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes |
Sanath K. Meegalla, Mark R. Player, Michael Winters |
2018-10-23 |
| 9920040 |
GPR40 agonists for the treatment of type II diabetes |
Sanath K. Meegalla, Mark R. Player |
2018-03-20 |
| 9908873 |
GPR40 agonists for the treatment of type II diabetes |
Sanath K. Meegalla, Mark R. Player |
2018-03-06 |
| 9856245 |
GPR40 agonists for the treatment of type II diabetes |
Sanath K. Meegalla, Mark R. Player |
2018-01-02 |
| 9845552 |
Set membership testers for aligning nucleic acid samples |
Erich D. Blume, John P. Burke |
2017-12-19 |
| 9790198 |
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes |
Gee-Hong Kuo, Mark R. Player, Shyh-Ming Yang, Yue-Mei Zhang |
2017-10-17 |
| 9688642 |
Substituted pyrazines as GPR40 agonists |
Sanath K. Meegalla, Mark R. Player |
2017-06-27 |
| 9301983 |
Composition and method of Lactobacillus reuteri GMNL-89 in treating type 2 diabetes |
Yi-Hsing Chen, Feng-Ching Hsieh |
2016-04-05 |
| 9249163 |
PDE10a inhibitors for the treatment of type II diabetes |
Mark R. Player, Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth Wilson +4 more |
2016-02-02 |
| 9193736 |
PDE 10a inhibitors for the treatment of type II diabetes |
Mark R. Player, Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth Wilson +4 more |
2015-11-24 |
| 8796256 |
Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators |
Gilles Bignan, Wing S. Cheung, Micheal Gaul, Xun Li, Raymond J. Patch +5 more |
2014-08-05 |
| 7728003 |
5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
Mark R. Player, Hu Huaping, Renee Louise Desjarlais |
2010-06-01 |
| 7642270 |
5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase |
Mark R. Player, Daniel A. Hutta, Renee Louise Desjarlais |
2010-01-05 |
| 7550474 |
Substituted phenyl acetamides and their use as protease inhibitors |
Kevin D. Kreutter, Lily Lee, Tianbao Lu, Venkatraman Mohan, Sharmila Patel +2 more |
2009-06-23 |
| 7138530 |
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
Nalin Subasinghe, Ehab M. Khalil, Kristi A. Leonard, Farah Ali, Heather Rae Hufnagel +10 more |
2006-11-21 |
| 7109354 |
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
Nalin Subasinghe, Ehab M. Khalil, Kristi A. Leonard, Farah Ali, Heather Rae Hufnagel +10 more |
2006-09-19 |
